Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05700396 · ClinicalTrials.gov registry record · NA

Breast Cancer Survivor Educational Intervention

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
7
Enrollment target

NCT05700396: Completed NA study, sponsored by Massachusetts General Hospital.

NCT05700396 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05700396, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
7 participants
Enrollment target

Study Summary

The goal of this study is to test a 6-week virtual education program among Black breast cancer survivors. The virtual program includes sessions on physical activity, goal setting, nutrition, sleep, stress, and social connections.

Interventions

  • BEHAVIORAL Breast Cancer Survivor Education Program

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2023-02-28
Est. Completion 2023-12-31
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT05700396

The ClinicalTrials.gov registry entry for NCT05700396 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Breast Cancer Survivor Education Program is the first listed.

NCT05700396 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05700396 about?

NCT05700396 is a clinical study titled "Breast Cancer Survivor Educational Intervention". The goal of this study is to test a 6-week virtual education program among Black breast cancer survivors. The virtual program includes sessions on physical activity, goal setting, nutrition, sleep, stress, and social connections.

What is the current status of trial NCT05700396?

This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2023-02-28. Estimated completion is 2023-12-31.

What interventions are being tested in trial NCT05700396?

The interventions under investigation include: Breast Cancer Survivor Education Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT05700396?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.